Search Results - "Merola, Roberta"

Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer by Ronchetti, Livia, Terrenato, Irene, Ferretti, Margherita, Corrado, Giacomo, Goeman, Frauke, Donzelli, Sara, Mandoj, Chiara, Merola, Roberta, Zampa, Ashanti, Carosi, Mariantonia, Blandino, Giovanni, Conti, Laura, Lobascio, Anna Maria, Iacobelli, Marcello, Vizza, Enrico, Piaggio, Giulia, Gurtner, Aymone

“…Cancer mortality is mainly caused by organ failure and thrombotic events. It has been demonstrated that NETosis, a chromatin release mechanism implemented by…”
Get full text

Correction: Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer by Ronchetti, Livia, Terrenato, Irene, Ferretti, Margherita, Corrado, Giacomo, Goeman, Frauke, Donzelli, Sara, Mandoj, Chiara, Merola, Roberta, Zampa, Ashanti, Carosi, Mariantonia, Blandino, Giovanni, Conti, Laura, Lobascio, Anna Maria, Iacobelli, Marcello, Vizza, Enrico, Piaggio, Giulia, Gurtner, Aymone

Get full text

Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial by Terrenato, Irene, Sperati, Francesca, Musicco, Felice, Pozzi, Anna F., di Turi, Annunziata, Caterino, Mauro, de Lutio di Castelguidone, Elisabetta, Setola, Sergio V., Bellomi, Massimo, Neumaier, Carlo E., Conti, Laura, Cigliana, Giovanni, Merola, Roberta, Antenucci, Anna, Orlandi, Giulia, Giordano, Antonio, Barba, Maddalena, Canitano, Stefano

“…To assess the safety profile of iso‐osmolar contrast medium (CM) versus low osmolar CM in cancer patients with an estimated glomerular filtration rate (eGFR)…”
Get full text

Long-Term Response in a Patient with del(5q) Myelodysplastic Syndrome Who Discontinued Lenalidomide and Obtained a Good Response and Tolerance to Rechallenge by Pisani, Francesco, Orlandi, Giulia, Merola, Roberta

“…Background: The introduction of the immunomodulatory drug lenalidomide has revolutionized the treatment of patients with myelodysplastic syndromes (MDS) and…”
Get full text

Epidermal growth factor receptor gene copy number may predict lapatinib sensitivity in HER2-positive metastatic breast cancer by Fabi, Alessandra, Merola, Roberta, Ferretti, Gianluigi, Di Benedetto, Anna, Antoniani, Barbara, Ercolani, Cristiana, Nisticò, Cecilia, Papaldo, Paola, Ciccarese, Mariangela, Sperduti, Isabella, Vici, Patrizia, Marino, Mirella, Gori, Stefania, Botti, Claudio, Malaguti, Paola, Cognetti, Francesco, Mottolese, Marcella

“…Lapatinib, a dual HER2/EGFR tyrosine kinase inhibitor (TKI), associated to capecitabine represents the treatment of choice in HER2-positive metastatic breast…”
Get more information

Epithelial-Restricted Gene Profile of Primary Cultures from Human Prostate Tumors: A Molecular Approach to Predict Clinical Behavior of Prostate Cancer by Nanni, Simona, Priolo, Carmen, Grasselli, Annalisa, D'Eletto, Manuela, Merola, Roberta, Moretti, Fabiola, Gallucci, Michele, De Carli, Piero, Sentinelli, Steno, Cianciulli, Anna Maria, Mottolese, Marcella, Carlini, Paolo, Arcelli, Diego, Helmer-Citterich, Mauro, Gaetano, Carlo, Loda, Massimo, Pontecorvi, Alfredo, Bacchetti, Silvia, Sacchi, Ada, Farsetti, Antonella

“…The histopathologic and molecular heterogeneity of prostate cancer and the limited availability of human tumor tissue make unraveling the mechanisms of…”
Get full text

Regaining the response to erythropoietin following azacitidine in chronic myelomonocytic leukemia previously evolved from refractory anemia by Niscola, Pasquale, Tendas, Andrea, Merola, Roberta, Orlandi, Giulia, Scaramucci, Laura, de Fabritiis, Paolo

“…KCI Citation Count: 0…”
Get full text

Epidermal growth factor receptor gene copy number in 101 advanced colorectal cancer patients treated with chemotherapy plus cetuximab by Campanella, Carla, Mottolese, Marcella, Cianciulli, Anna, Torsello, Angela, Merola, Roberta, Sperduti, Isabella, Melucci, Elisa, Conti, Salvatore, Diodoro, Maria Grazia, Zeuli, Massimo, Paoletti, Giancarlo, Cognetti, Francesco, Garufi, Carlo

“…Responsiveness to Cetuximab alone can be mediated by an increase of Epidermal Growth factor Receptor (EGFR) Gene Copy Number (GCN). Aim of this study was to…”
Get full text

Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy by Niscola, Pasquale, Tendas, Andrea, Scaramucci, Laura, Merola, Roberta, Catalano, Gianfranco, de Fabritiis, Paolo

“…KCI Citation Count: 0…”
Get full text

Genetic profile identification in clinically localized prostate carcinoma by Gallucci, Michele, M.D, Merola, Roberta, Ph.D, Leonardo, Costantino, M.D, De Carli, Piero, M.D, Farsetti, Antonella, M.D, Sentinelli, Steno, M.D, Sperduti, Isabella, Ph.D, Mottolese, Marcella, Ph.D, Carlini, Paolo, M.D, Vico, Erika, Ph.D, Simone, Giuseppe, M.D, Cianciulli, AnnaMaria, Ph.D

“…Abstract Purpose To confirm our previously obtained results, we genetically characterized prostate cancer from patients undergo radical prostatectomy in a…”
Get full text

Comprehensive Characterization of Cancer Driver Genes and Mutations by Colaprico, Antonio, Cao, Song, Liang, Wen-Wei, Hess, Julian M., Ferguson, Martin L., Hutter, Carolyn M., Tarnuzzer, Roy, Wang, Zhining, Noble, Michael S., Dhankani, Varsha, Knijnenburg, Theo, Miller, Michael, Abeshouse, Adam, Ladanyi, Marc, Luna, Augustin, Wong, Christopher K., Yau, Christina, Kasaian, Katayoon, Kucherlapati, Melanie H., Danilova, Ludmila, Bootwalla, Moiz S., Fan, Cheng, Mose, Lisle E., Roach, Jeffrey, Tan, Donghui, Covington, Kyle, Donehower, Lawrence A., Drummond, Jennifer, Liu, Xiuping, Morgan, Margaret, Wheeler, David A., Appelbaum, Elizabeth L., Bailey, Matthew, Kandoth, Cyriac, Wilson, Richard K., Penny, Robert, Thompson, Eric, Zmuda, Erik, de Carvalho, Ana C., Fregnani, José H., Huntsman, David, Kohl, Bernard, Paklina, Oxana, McPherson, Christopher, Barnholtz-Sloan, Jill S., Tucker, Kelinda, Larson, Caroline, Iacocca, Mary, Bergeron, Alain, Sepulveda, Antonia, Desjardins, Laurence, Sastre, Xavier, Cheng, Feixiong, Force, Seth, Khuri, Fadlo, Owonikoko, Taofeek, Korpershoek, Esther, Looijenga, Leendert, DiMeco, Francesco, Kycler, Witold, Chung, Ki, Noushmehr, Houtan, Scarpace, Lisa, Campo, Elias, Van Bang, Nguyen, Colman, Howard, Breggia, Anne, Bryce, Alan H., Copland, John A., Petersen, Gloria, Zhang, Lizhi, Mann, Graham, Mirsaidi, Cyrus, Zaren, Howard, Stancul, Irina, Tcaciuc, Diana, Arnaout, Angel, Rassl, Doris M., Urba, Walter, Farver, Carol, Raymond, Daniel, Dinkin, Mikhail, Carpino, Guido, Dubina, Michael, Abdel-Rahman, Mohamed H., Mandt, Randy, Nguyen, Phuong, Rai, Karan, Waldmann, Jens, Fassnacht, Martin, Simon, Ronald, Fehrenbach, Ashley, von Deimling, Andreas, Jacobus, Laura, Carlotti, Carlos Gilberto, Godwin, Eryn M., Carey, Thomas, Getz, Gad, Lazar, Alexander J., Ding, Li

“…Identifying molecular cancer drivers is critical for precision oncology. Multiple advanced algorithms to identify drivers now exist, but systematic attempts to…”
Get full text

Pathogenic Germline Variants in 10,389 Adult Cancers by Ritter, Deborah I., Reynolds, Sheila, Houlahan, Kathleen E., Cho, Juok, Reynolds, Sheila, Akbani, Rehan, Phillips, Sarah M., Zhang, Hongxin, Balasundaram, Miruna, Chuah, Eric, Holt, Robert, Schein, Jacqueline E., Sipahimalani, Payal, Thiessen, Nina, Beroukhim, Rameen, Cope, Leslie, Weisenberger, Daniel J., Hoyle, Alan P., Jefferys, Stuart R., Mieczkowski, Piotr A., Perou, Amy H., Shi, Yan, Veluvolu, Umadevi, Fan, Huihui, Donehower, Lawrence A., Ding, Li, Mardis, Elaine R., Curley, Erin, Mallery, David, Paulauskis, Joseph, Lichtenberg, Tara M., Eschbacher, Jennifer, Ittmann, Michael, Andry, Chris, Tavobilov, Mikhail, Cramer, Daniel, Barrett, Wendi, Karlan, Beth Y., Zach, Leigh Anne, Hu, Hai, Swanson, Patricia, Chabot, John, Su, Tao, Voronina, Olga, Signoretti, Sabina, Berchuck, Andrew, Houck, John, Hartmann, Arndt, Hanh, Phan Thi, Juhl, Hartmut, Kopp, Karla, Roberts, Lewis, Yang, Ju Dong, Moran, Cesar, Ramondetta, Lois, Troncoso, Patricia, Tsao, Anne, Wistuba, Ignacio, Scolyer, Richard, Stretch, Jonathan, Wilmott, James, Reuter, Victor, Park, Joong-Won, Hung, Nguyen Phi, Kebebew, Electron, Pinto, Peter A., Moncrieff, Marc, Pass, Harvey, Botnariuc, Natalia, Pirtac, Maria, Tamakawa, Raina, Antenucci, Anna, Facciolo, Francesco, Chevalier, Simone, Brewer, Cathy, Pennell, Nathan A., Omberg, Larsson, Pilarski, Robert, Senecal, Kelly, Schadendorf, Dirk, Sauter, Guido, Olabode, Oluwole, Disaia, Philip, Roggin, Kevin, Mannelli, Massimo, Postier, Russel, Walker, Joan, Feldman, Michael, Dhir, Rajiv, Luketich, James, Prince, Mark, Rozek, Laura, Fong, Kwun M., Shriver, Craig D., Govindan, Ramaswamy, Heath, Sharon, Aredes, Natália D., Wendl, Michael C., Reimand, Jüri, Meric-Bernstam, Funda

“…We conducted the largest investigation of predisposition variants in cancer to date, discovering 853 pathogenic or likely pathogenic variants in 8% of 10,389…”
Get full text

Circulating cell-free DNA content as blood based biomarker in endometrial cancer by Cicchillitti, Lucia, Corrado, Giacomo, De Angeli, Martina, Mancini, Emanuela, Baiocco, Ermelinda, Patrizi, Lodovico, Zampa, Ashanti, Merola, Roberta, Martayan, Aline, Conti, Laura, Piaggio, Giulia, Vizza, Enrico

“…Altered circulating cell-free DNA (cfDNA) levels are related to cancer development and aggressiveness. Up to now, very few studies have been performed for…”
Get full text

Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas by Campbell, Joshua D., Liu, Yuexin, Byers, Lauren Averett, Zuna, Rosemary, Al-Ahmadie, Hikmat, Flores, Elsa R., Tsai, Kenneth Y., Felau, Ina, Zhang, Jiashan (Julia), Meier, Sam, Bernard, Brady, Zhang, Jiexin, Gross, Benjamin E., Nissan, Moriah G., Phillips, Sarah M., Zhang, Hongxin, Bowlby, Reanne, Mungall, Karen, Schein, Jacqueline E., Sipahimalani, Payal, Tse, Kane, Cope, Leslie, Lai, Phillip H., Van Den Berg, David J., Jefferys, Stuart R., Mieczkowski, Piotr A., Soloway, Matthew G., Veluvolu, Umadevi, Fan, Huihui, Zhou, Wanding, Bellair, Michelle, Doddapaneni, HarshaVardhan, Muzny, Donna, Xi, Liu, Mardis, Elaine R., Morris, Scott, Paulauskis, Joseph, Gastier-Foster, Julie M., Lichtenberg, Tara M., Carvalho, Andre L., Silveira, Henrique C.S., Burnette, Andrew, Noss, Ardene, Ittmann, Michael, Andry, Chris, Lyadov, Vladimir, Raut, Chandrajit P., Têtu, Bernard, Chabot, John, Potapova, Olga, Bigner, Darell, Secord, Angeles, Ramalingam, Suresh, Mattei, Luca, Houck, John, Guillermo, Armando López, Kang, Koo Jeong, Thompson, R. Houston, Yang, Ju Dong, Bondaruk, Jolanta, Broaddus, Russell, Fujimoto, Junya, Thompson, Timothy, Tsao, Anne, Wistuba, Ignacio, Haydu, Lauren, Hersey, Peter, Lee, Kenneth, Spillane, Andrew, Drwiega, Paul, Park, Joong-Won, Hung, Nguyen Phi, Kebebew, Electron, Pacak, Karel, Schmidt, Laura S., Gorincioi, Ghenadie, Thomas, George, Tamakawa, Raina, Smolenski, Kathy, Alvaro, Domenico, Bragazzi, Maria Consiglia, Chesla, David, Becker, Karl-Friedrich, Schoenfield, Lynn, Senecal, Kelly, Tischler, Arthur, Nelson, Mark, Carroll, Peter R., Carey, Francis, Forgie, Ian, Carney, Michael, Godwin, Andrew K., Bocklage, Therese, Valdivieso, Federico, Dhir, Rajiv, Sankarankuty, Ajith, Fantacone-Campbell, J. Leigh, Kovatich, Albert J., Weinstein, John N., Peto, Myron

“…This integrated, multiplatform PanCancer Atlas study co-mapped and identified distinguishing molecular features of squamous cell carcinomas (SCCs) from five…”
Get full text

Clinical Features and Treatment Response in Patients with Multiple Myeloma and CD20 Expression: Real-Life Experience of the Centro-Italy Multiple Myeloma Macroregional District by Fiorini, Alessia, Panichi, Valentina, Chavez, Maria Gabriela, Cordone, Iole, Montanaro, Guido, Fazio, Francesca, Bassi, Loredana, Tomarchio, Valeria, Sbraga, Edoardo, Poscente, Monica, Merola, Roberta, De Propris, Maria Stefania, Mengarelli, Andrea, Licci, Stefano, Giancola, Raffaella, Latagliata, Roberto, Annibali, Ombretta, Rago, Angela, Fioritoni, Francesca, Petrucci, Maria Teresa, Andriani, Alessandro

Get full text

PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience by Merola, Roberta, Tomao, Luigi, Antenucci, Anna, Sperduti, Isabella, Sentinelli, Steno, Masi, Serena, Mandoj, Chiara, Orlandi, Giulia, Papalia, Rocco, Guaglianone, Salvatore, Costantini, Manuela, Cusumano, Giuseppe, Cigliana, Giovanni, Ascenzi, Paolo, Gallucci, Michele, Conti, Laura

“…Prostate cancer (PCa) is the most common male cancer in Europe and the US. The early diagnosis relies on prostate specific antigen (PSA) serum test, even if it…”
Get full text

Abstract 350: Che-1/aatf-induced transcriptionally active chromatin promotes cell growth in multiple myeloma by Bruno, Tiziana, Nicola, Francesca De, Goeman, Frauke, Pallocca, Matteo, Sorino, Cristina, Catena, Valeria, Bossi, Gianluca, Amadio, Bruno, Cigliana, Giovanni, Spugnini, Enrico, Ricciardi, Maria Rosaria, Petrucci, Maria Teresa, Baldi, Alfonso, Cioce, Mario, Cortese, Giancarlo, Mattei, Elisabetta, Merola, Roberta, Gianelli, Umberto, Pisani, Francesco, Gumenyuk, Svitlana, Mengarelli, Andrea, Hopker, Katja, Benzing, Thomas, Floridi, Aristide, Passananti, Claudio, Blandino, Giovanni, Iezzi, Simona, Fanciulli, Maurizio

“…Abstract Tumor transformation is the result of genetic and epigenetic modifications that alter gene transcription, consequently producing a specific oncogenic…”
Get full text

Temozolomide Low-dose Chemotherapy in Newly Diagnosed Low-grade Gliomas: Activity, Safety, and Long-term Follow-up by Villani, Veronica, Merola, Roberta, Vidiri, Antonello, Fabi, Alessandra, Carosi, Mariantonia, Giannarelli, Diana, Marucci, Laura, Maschio, Marta, Carapella, Carmine M., Pace, Andrea

“…Purpose To explore the efficacy and toxicity of an extended schedule of temozolomide (50 mg/mq 1 week on/1 week off) in a population of newly diagnosed…”
Get full text

Flow cytometry characterization in central nervous system and pleural effusion multiple myeloma infiltration: an Italian national cancer institute experience by Marchesi, Francesco, Masi, Serena, Summa, Valentina, Gumenyuk, Svitlana, Merola, Roberta, Orlandi, Giulia, Cigliana, Giovanni, Palombi, Francesca, Pisani, Francesco, Romano, Atelda, Spadea, Antonio, Papa, Elena, Canfora, Marco, De Bellis, Francesco, Conti, Laura, Mengarelli, Andrea, Cordone, Iole

Get full text

EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapy by Milella, Michele, Nuzzo, Carmen, Bria, Emilio, Sperduti, Isabella, Visca, Paolo, Buttitta, Fiamma, Antoniani, Barbara, Merola, Roberta, Gelibter, Alain, Cuppone, Federica, D'Alicandro, Valerio, Ceribelli, Anna, Rinaldi, Massimo, Cianciulli, Anna, Felicioni, Lara, Malatesta, Sara, Marchetti, Antonio, Mottolese, Marcella, Cognetti, Francesco

“…The optimal use of epidermal growth factor receptor (EGFR)-related molecular markers to prospectively identify tyrosine kinase inhibitor (TKI)-sensitive…”
Get more information